AI's Expanding Role in Diabetes Care
Machine learning models applied to inpatient electronic health record data have predicted insulin needs more accurately than traditional guidelines.
Artificial intelligence (AI) is significantly transforming diabetes care through advancements in complication screening, risk stratification, and treatment optimization. With a global diabetes prevalence projected to rise from 537 million to 783 million by 2045, AI technologies, including machine learning, are being utilized to enhance clinical workflows, enabling early detection and personalized treatment. Dr. Rohit Parab and colleagues highlight AI's potential in optimizing insulin delivery and improving patient self-management, amidst ongoing challenges related to data privacy and model reliability.
1. AI reshapes diabetes care through complication screening and risk stratification. 2. Projected 783 million with diabetes by 2045. 3. AI advances early detection of diabetic retinopathy and neuropathy. 4. AI enhances insulin optimization and glycemic control. 5. Patient self-management improved by AI interventions. 6. Challenges include privacy, model reliability, and demographic representation. 7. AI applications extend to administrative tasks and resource allocation.